3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Carcinoma, Renal Cell
3
Triple Negative Breast Neoplasms
2
Lung Neoplasms
2
Kidney Neoplasms
2
Adenocarcinoma Of Esophagus
2
Uterine Cervical Neoplasms
1
Urothelial Bladder Carcinoma
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Recurrence
1
Ovarian Neoplasms
1
Metastatic Urothelial Cancer
1
Melanoma
1
Lung Diseases
1
Glioblastoma
1
Esophageal Neoplasms
1
Erythrocytosis, Familial, 4
1
Cholangiocarcinoma
1
Advanced Solid Tumors
1
Advanced Non-Small Cell Lung Cancer
1
Interventions
pembrolizumab
3
lenvatinib
2
Specimen Handling
2
Nivolumab
2
Cisplatin
2
trastuzumab deruxtecan
1
tivozanib
1
liposomal doxorubicin
1
entinostat
1
dostarlimab
1
bintrafusp alfa protein, human
1
atezolizumab
1
Therapeutic Touch
1
Surveys and Questionnaires
1
Radiotherapy
1
Radiation
1
Platinum
1
Paclitaxel
1
Nelfinavir
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Gemcitabine
1
Doxorubicin
1
Dehydroepiandrosterone
1
CTLA-4 Antigen
1
Bupropion
1
Blood Specimen Collection
1
Bevacizumab
1
Axitinib
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Vulvar Neoplasms
×
zimberelimab
×
90 days
×
Clear all
No trials found.